O9-1 Frequency, localization and clinical aspects of the brain tumors in children with neurofibromatosis von Recklinghausen type 1

Introduction: Brain tumor is among the major causes of morbidity and mortality rates worldwide. According to National Brain Tumor Foundation (NBTS), the death rate has nearly increased by as much as 300% over last couple of decades. Tumors can be categorized as benign (non-cancerous) and malignant (cancerous). The type of the brain tumor significantly depends on various factors like the site of its occurrence, its shape, the age of the subject etc. On the other hand, Computer Aided Detection (CAD) has been improving significantly in recent times. The concept, design and implementation of these systems ascend from fairly simple ones to computationally intense ones. For efficient and effective diagnosis and treatment plans in brain tumor studies, it is imperative that an abnormality is detected at an early stage as it provides a little more time for medical professionals to respond. The early detection of diseases has predominantly been possible because of medical imaging techniques developed from past many decades like CT, MRI, PET, SPECT, FMRI etc. The detection of brain tumors however, has always been a challenging task because of the complex structure of the brain, diverse tumor sizes and locations in the brain. Method: This paper proposes an algorithm that can detect the brain tumors in the presence of the Radio-Frequency (RF) inhomoginiety. The algorithm utilizes the Mid Sagittal Plane as a landmark point across which the asymmetry between the two brain hemispheres is estimated using various intensity and texture based parameters. Result: The results show the efficacy of the proposed method for the detection of the brain tumors with an acceptable detection rate. Conclusion: In this paper, we have calculated three textural features from the two hemispheres of the brain viz: Contrast (CON), Entropy (ENT) and Homogeneity (HOM) and three parameters viz: Root Mean Square Error (RMSE), Correlation Co-efficient (CC), and Integral of Absolute Difference (IAD) from the intensity distribution profiles of the two brain hemispheres to predict any presence of the pathology. First a Mid Sagittal Plane (MSP) is obtained on the Magnetic Resonance Images that virtually divides brain into two bilaterally symmetric hemispheres. The block wise texture asymmetry is estimated for these hemispheres using the above 6 parameters.

Download Full-text

Beyond Oncological Hyperthermia: Physically Drivable Magnetic Nanobubbles as Novel Multipurpose Theranostic Carriers in the Central Nervous System

Molecules ◽

10.3390/molecules25092104 ◽

2020 ◽

Vol 25 (9) ◽

pp. 2104 ◽

Cited By ~ 1

Author(s):

Eleonora Ficiarà ◽

Shoeb Anwar Ansari ◽

Monica Argenziano ◽

Luigi Cangemi ◽

Chiara Monge ◽

...

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Brain Tumors ◽

Ad Hoc ◽

Superparamagnetic Iron Oxide ◽

Conventional Radiotherapy ◽

The Central Nervous System ◽

Magnetic Resonance Imaging Mri ◽

The Brain

Magnetic Oxygen-Loaded Nanobubbles (MOLNBs), manufactured by adding Superparamagnetic Iron Oxide Nanoparticles (SPIONs) on the surface of polymeric nanobubbles, are investigated as theranostic carriers for delivering oxygen and chemotherapy to brain tumors. Physicochemical and cyto-toxicological properties and in vitro internalization by human brain microvascular endothelial cells as well as the motion of MOLNBs in a static magnetic field were investigated. MOLNBs are safe oxygen-loaded vectors able to overcome the brain membranes and drivable through the Central Nervous System (CNS) to deliver their cargoes to specific sites of interest. In addition, MOLNBs are monitorable either via Magnetic Resonance Imaging (MRI) or Ultrasound (US) sonography. MOLNBs can find application in targeting brain tumors since they can enhance conventional radiotherapy and deliver chemotherapy being driven by ad hoc tailored magnetic fields under MRI and/or US monitoring.

Download Full-text

Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review

Journal of Neuro-Oncology ◽

10.1007/s11060-020-03652-z ◽

2021 ◽

Vol 151 (3) ◽

pp. 429-442

Author(s):

Clark Chen ◽

Ian Lee ◽

Claudio Tatsui ◽

Theresa Elder ◽

Andrew E. Sloan

Keyword(s):

Brain Tumors ◽

Minimally Invasive ◽

Radiation Necrosis ◽

Spinal Metastasis ◽

Clinical Approach ◽

Invasive Treatment ◽

Primary Indication ◽

Interstitial Thermotherapy ◽

The Brain

Abstract Introduction Laser Interstitial Thermotherapy (LITT; also known as Stereotactic Laser Ablation or SLA), is a minimally invasive treatment modality that has recently gained prominence in the treatment of malignant primary and metastatic brain tumors and radiation necrosis and studies for treatment of spinal metastasis has recently been reported. Methods Here we provide a brief literature review of the various contemporary uses for LITT and their reported outcomes. Results Historically, the primary indication for LITT has been for the treatment of recurrent glioblastoma (GBM). However, indications have continued to expand and now include gliomas of different grades, brain metastasis (BM), radiation necrosis (RN), other types of brain tumors as well as spine metastasis. LITT is emerging as a safe, reliable, minimally invasive clinical approach, particularly for deep seated, focal malignant brain tumors and radiation necrosis. The role of LITT for treatment of other types of tumors of the brain and for spine tumors appears to be evolving at a small number of centers. While the technology appears to be safe and increasingly utilized, there have been few prospective clinical trials and most published studies combine different pathologies in the same report. Conclusion Well-designed prospective trials will be required to firmly establish the role of LITT in the treatment of lesions of the brain and spine.

Download Full-text

Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture

Journal of Cerebral Blood Flow & Metabolism ◽

10.1177/0271678x21994395 ◽

2021 ◽

pp. 0271678X2199439

Author(s):

Cen Yang ◽

Jingjing Liu ◽

Jingyi Wang ◽

Anqi Yin ◽

Zhenhua Jiang ◽

...

Keyword(s):

Endocannabinoid System ◽

Artery Occlusion ◽

Ischemic Tolerance ◽

Protective Mechanisms ◽

Promising Therapeutic Approach ◽

Subsequent Activation ◽

Cerebral Ischemic ◽

Cerebral Artery Occlusion ◽

The Brain

There are no effective treatments for stroke. The activation of endogenous protective mechanisms is a promising therapeutic approach, which evokes the intrinsic ability of the brain to protect itself. Accumulated evidence strongly suggests that electroacupuncture (EA) pretreatment induces rapid tolerance to cerebral ischemia. With regard to mechanisms underlying ischemic tolerance induced by EA, many molecules and signaling pathways are involved, such as the endocannabinoid system, although the exact mechanisms have not been fully elucidated. In the current study, we employed mutant mice, neuropharmacology, microdialysis, and virus transfection techniques in a middle cerebral artery occlusion (MCAO) model to explore the cell-specific and brain region-specific mechanisms of EA-induced neuroprotection. EA pretreatment resulted in increased ambient endocannabinoid (eCB) levels and subsequent activation of ischemic penumbral astroglial cannabinoid type 1 receptors (CB1R) which led to moderate upregulation of extracellular glutamate that protected neurons from cerebral ischemic injury. These findings provide a novel cellular mechanism of EA and a potential therapeutic target for ischemic stroke.

Download Full-text

Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain

Frontiers in Bioscience ◽

10.2741/201 ◽

2011 ◽

Vol S3 (1) ◽

pp. 970 ◽

Cited By ~ 7

Author(s):

Matteo Fassan

Keyword(s):

Brain Tumors ◽

Primary Brain Tumors ◽

Secondary Tumors ◽

The Brain

Download Full-text

THE METABOLISM OF NORMAL BRAIN AND HUMAN GLIOMAS IN RELATION TO CELL TYPE AND DENSITY

Canadian Journal of Biochemistry and Physiology ◽

10.1139/o55-052 ◽

1955 ◽

Vol 33 (3) ◽

pp. 395-403 ◽

Cited By ~ 37

Author(s):

Irving H. Heller ◽

K. A. C. Elliott

Keyword(s):

Cerebral Cortex ◽

White Matter ◽

Brain Tumors ◽

Corpus Callosum ◽

Oxygen Uptake ◽

Glial Cells ◽

Cerebellar Cortex ◽

Unit Weight ◽

Uptake Rates ◽

The Brain

Per unit weight, cerebral and cerebellar cortex respire much more actively than corpus callosum. The rate per cell nucleus is highest in cerebral cortex, lower in corpus callosum, and still lower in cerebellar cortex. The oxygen uptake rates of the brain tumors studied, with the exception of an oligodendroglioma, were about the same as that of white matter on the weight basis but lower than that of cerebral cortex or white matter on the cell basis. In agreement with previous work, an oligodendroglioma respired much more actively than the other tumors. The rates of glycolysis of the brain tumors per unit weight were low but, relative to their respiration rate, glycolysis was higher than in normal gray or white matter. Consideration of the figures obtained leads to the following tentative conclusions: Glial cells of corpus callosum respire more actively than the neurons of the cerebellar cortex. Neurons of the cerebral cortex respire on the average much more actively than neurons of the cerebellar cortex or glial cells. Considerably more than 70% of the oxygen uptake by cerebral cortex is due to neurons. The oxygen uptake rates of normal oligodendroglia and astrocytes are probably about the same as the rates found per nucleus in an oligodendroglioma and in astrocytomas; oligodendroglia respire much more actively than astrocytes.

Download Full-text

Thymidine kinase-mediated killing of rat brain tumors

Journal of Neurosurgery ◽

10.3171/jns.1993.79.5.0729 ◽

1993 ◽

Vol 79 (5) ◽

pp. 729-735 ◽

Cited By ~ 101

Author(s):

David Barba ◽

Joseph Hardin ◽

Jasodhara Ray ◽

Fred H. Gage

Keyword(s):

Gene Therapy ◽

Brain Tumors ◽

Tumor Cells ◽

Wild Type ◽

Cns Disorders ◽

Content Type ◽

Potential Applications ◽

Ganciclovir Treatment ◽

The Brain ◽

Fine Print

✓ Gene therapy has many potential applications in central nervous system (CNS) disorders, including the selective killing of tumor cells in the brain. A rat brain tumor model was used to test the herpes simplex virus (HSV)-thymidine kinase (TK) gene for its ability to selectively kill C6 and 9L tumor cells in the brain following systemic administration of the nucleoside analog ganciclovir. The HSV-TK gene was introduced in vitro into tumor cells (C6-TK and 9L-TK), then these modified tumor cells were evaluated for their sensitivity to cell killing by ganciclovir. In a dose-response assay, both C6-TK and 9L-TK cells were 100 times more sensitive to killing by ganciclovir (median lethal dose: C6-TK, 0.1 µg ganciclovir/ml; C6, 5.0 µg ganciclovir/ml) than unmodified wild-type tumor cells or cultured fibroblasts. In vivo studies confirmed the ability of intraperitoneal ganciclovir administration to kill established brain tumors in rats as quantified by both stereological assessment of brain tumor volumes and studies of animal survival over 90 days. Rats with brain tumors established by intracerebral injection of wild-type or HSV-TK modified tumor cells or by a combination of wild-type and HSV-TK-modified cells were studied with and without ganciclovir treatments. Stereological methods determined that ganciclovir treatment eliminated tumors composed of HSV-TK-modified cells while control tumors grew as expected (p < 0.001). In survival studies, all 10 rats with 9L-TK tumors treated with ganciclovir survived 90 days while all untreated rats died within 25 days. Curiously, tumors composed of combinations of 9L and 9L-TK cells could be eliminated by ganciclovir treatments even when only one-half of the tumor cells carried the HSV-TK gene. While not completely understood, this additional tumor cell killing appears to be both tumor selective and local in nature. It is concluded that HSV-TK gene therapy with ganciclovir treatment does selectively kill tumor cells in the brain and has many potential applications in CNS disorders, including the treatment of cancer.

Download Full-text